RepliCel Long Term Debt vs Net Receivables Analysis

RP Stock  CAD 0.01  0.01  50.00%   
RepliCel Life financial indicator trend analysis is much more than just breaking down RepliCel Life Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RepliCel Life Sciences is a good investment. Please check the relationship between RepliCel Life Long Term Debt and its Net Receivables accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Long Term Debt vs Net Receivables

Long Term Debt vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RepliCel Life Sciences Long Term Debt account and Net Receivables. At this time, the significance of the direction appears to have almost no relationship.
Long Term DebtNet ReceivablesDiversified AwayLong Term DebtNet ReceivablesDiversified Away100%
The correlation between RepliCel Life's Long Term Debt and Net Receivables is 0.19. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Net Receivables in the same time period over historical financial statements of RepliCel Life Sciences, assuming nothing else is changed. The correlation between historical values of RepliCel Life's Long Term Debt and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of RepliCel Life Sciences are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Long Term Debt i.e., RepliCel Life's Long Term Debt and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.19
Relationship DirectionPositive 
Relationship StrengthInsignificant

Long Term Debt

Long-term debt is a debt that RepliCel Life Sciences has held for over one year. Long-term debt appears on RepliCel Life Sciences balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on RepliCel Life Sciences balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Net Receivables

Most indicators from RepliCel Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, RepliCel Life's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 5.46 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.54) in 2024.

RepliCel Life fundamental ratios Correlations

0.19-0.190.490.34-0.810.12-0.150.810.00.980.3-0.290.41-0.220.99-0.530.020.58-0.310.33-0.310.13-0.230.340.19
0.19-0.140.350.20.040.06-0.290.15-0.250.22-0.210.150.29-0.310.22-0.17-0.040.41-0.4-0.09-0.550.260.050.20.11
-0.19-0.14-0.87-0.870.3-0.950.71-0.160.8-0.350.650.82-0.340.91-0.280.70.88-0.39-0.40.30.68-0.440.85-0.94-0.95
0.490.35-0.870.87-0.490.84-0.510.39-0.770.61-0.47-0.770.37-0.960.57-0.88-0.730.70.17-0.1-0.880.52-0.760.970.87
0.340.2-0.870.87-0.430.88-0.40.27-0.730.48-0.5-0.860.57-0.870.41-0.84-0.790.650.05-0.17-0.80.6-0.840.90.95
-0.810.040.3-0.49-0.43-0.340.08-0.950.08-0.8-0.140.48-0.280.29-0.810.620.19-0.660.14-0.270.28-0.110.43-0.42-0.34
0.120.06-0.950.840.88-0.34-0.580.19-0.750.28-0.68-0.850.32-0.90.2-0.73-0.940.440.4-0.32-0.680.37-0.920.930.97
-0.15-0.290.71-0.51-0.40.08-0.58-0.130.52-0.270.560.27-0.230.52-0.20.140.610.02-0.450.530.270.030.41-0.51-0.54
0.810.15-0.160.390.27-0.950.19-0.130.040.790.13-0.230.29-0.160.8-0.45-0.090.61-0.210.22-0.22-0.03-0.260.270.18
0.0-0.250.8-0.77-0.730.08-0.750.520.04-0.160.610.55-0.260.86-0.10.580.74-0.43-0.270.510.76-0.60.53-0.78-0.79
0.980.22-0.350.610.48-0.80.28-0.270.79-0.160.14-0.380.52-0.360.99-0.59-0.150.61-0.240.18-0.410.2-0.360.470.35
0.3-0.210.65-0.47-0.5-0.14-0.680.560.130.610.140.35-0.130.620.230.20.75-0.04-0.560.510.4-0.050.52-0.53-0.66
-0.290.150.82-0.77-0.860.48-0.850.27-0.230.55-0.380.35-0.220.79-0.350.860.69-0.48-0.26-0.110.58-0.480.88-0.87-0.87
0.410.29-0.340.370.57-0.280.32-0.230.29-0.260.52-0.13-0.22-0.280.43-0.31-0.320.44-0.41-0.3-0.410.38-0.430.330.43
-0.22-0.310.91-0.96-0.870.29-0.90.52-0.160.86-0.360.620.79-0.28-0.30.820.82-0.59-0.290.210.88-0.540.79-0.98-0.92
0.990.22-0.280.570.41-0.810.2-0.20.8-0.10.990.23-0.350.43-0.3-0.58-0.060.63-0.280.28-0.390.19-0.280.420.27
-0.53-0.170.7-0.88-0.840.62-0.730.14-0.450.58-0.590.20.86-0.310.82-0.580.56-0.840.05-0.240.82-0.590.74-0.88-0.77
0.02-0.040.88-0.73-0.790.19-0.940.61-0.090.74-0.150.750.69-0.320.82-0.060.56-0.33-0.430.470.62-0.290.82-0.82-0.91
0.580.41-0.390.70.65-0.660.440.020.61-0.430.61-0.04-0.480.44-0.590.63-0.84-0.33-0.410.2-0.790.55-0.440.610.5
-0.31-0.4-0.40.170.050.140.4-0.45-0.21-0.27-0.24-0.56-0.26-0.41-0.29-0.280.05-0.43-0.41-0.30.15-0.39-0.340.280.31
0.33-0.090.3-0.1-0.17-0.27-0.320.530.220.510.180.51-0.11-0.30.210.28-0.240.470.2-0.30.10.050.13-0.11-0.31
-0.31-0.550.68-0.88-0.80.28-0.680.27-0.220.76-0.410.40.58-0.410.88-0.390.820.62-0.790.150.1-0.710.57-0.83-0.74
0.130.26-0.440.520.6-0.110.370.03-0.03-0.60.2-0.05-0.480.38-0.540.19-0.59-0.290.55-0.390.05-0.71-0.320.520.45
-0.230.050.85-0.76-0.840.43-0.920.41-0.260.53-0.360.520.88-0.430.79-0.280.740.82-0.44-0.340.130.57-0.32-0.87-0.89
0.340.2-0.940.970.9-0.420.93-0.510.27-0.780.47-0.53-0.870.33-0.980.42-0.88-0.820.610.28-0.11-0.830.52-0.870.94
0.190.11-0.950.870.95-0.340.97-0.540.18-0.790.35-0.66-0.870.43-0.920.27-0.77-0.910.50.31-0.31-0.740.45-0.890.94
Click cells to compare fundamentals

RepliCel Life Account Relationship Matchups

RepliCel Life fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets505.5K421.0K591.8K798.2K287.8K273.4K
Total Current Liabilities1.6M2.2M1.7M2.1M1.8M1.9M
Total Stockholder Equity(4.4M)(5.1M)(6.8M)(5.9M)(4.5M)(4.3M)
Property Plant And Equipment Net6.0K4.4K3.3K2.4K967.0918.65
Net Debt425.4K41.7K(186.9K)(372.1K)754.0K791.7K
Retained Earnings(36.6M)(38.2M)(42.2M)(43.0M)(43.3M)(41.1M)
Accounts Payable640.3K1.3M602.0K817.9K416.0K472.3K
Cash23.9K34.4K221.2K413.0K59.2K56.2K
Non Current Assets Total272.2K235.3K198.8K162.5K125.7K119.4K
Cash And Short Term Investments52.7K51.6K238.4K430.3K76.4K72.6K
Net Receivables51.9K63.6K61.2K82.2K38.0K39.0K
Common Stock Shares Outstanding24.1M27.0M32.5M37.8M59.2M62.2M
Liabilities And Stockholders Equity505.5K421.0K591.8K798.2K287.8K273.4K
Other Stockholder Equity4.6M4.6M5.1M5.4M5.6M5.6M
Total Liab4.9M5.5M7.4M6.7M4.8M5.1M
Total Current Assets233.2K185.7K393.0K635.7K162.1K154.0K
Short Term Debt449.3K47.3K611.4K689.3K813.2K853.8K
Common Stock27.5M28.5M30.3M31.7M33.1M20.0M
Other Current Liab107.3K517.8K106.6K211.8K239.5K432.0K
Other Assets266.2K230.8K195.5K1.01.151.09
Non Current Liabilities Total3.4M3.2M5.8M4.6M3.0M2.1M
Other Current Assets128.7K70.5K93.4K123.2K47.7K89.2K
Net Tangible Assets(1.9M)(4.4M)(5.1M)(6.8M)(6.2M)(5.9M)
Property Plant Equipment8.2K6.0K4.4K3.3K2.9K2.8K
Net Invested Capital(2.9M)(5.0M)(6.8M)(5.9M)(5.3M)(5.6M)
Net Working Capital(1.2M)(2.1M)(1.3M)(1.4M)(1.3M)(1.4M)
Capital Stock29.0M28.5M30.3M31.7M36.4M32.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.